The 20 Best Hemoglobinopathy Doctors near Bronx, NY

Susanna Curtis is an Oncologist in Bronx, New York. Dr. Curtis is rated as an Elite provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Caterina Minniti is a Hematologist and an Oncologist in Bronx, New York. Dr. Minniti is rated as an Elite provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia.

Deepa Manwani is a Hematologist and an Oncologist in Bronx, New York. Dr. Manwani is rated as an Elite provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Splenectomy, and Bone Marrow Transplant.

Patricia Ann Shi, MD, MS, is an attending physician at Montefiore Einstein and Associate Professor, Hematology at our Albert Einstein College of Medicine. Dr. Shi specializes in transfusion medicine, with a particular focus on apheresis, and in benign hematology, especially the treatment of sickle cell disease. Dr. Shi is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Kerry Morrone, MD, is an Assistant Professor of Pediatrics at the Albert Einstein College of Medicine, the Director of the Sickle Cell Program and the Director of the Pediatric Hematology Oncology Fellowship Program at Montefiore. Dr. Morrone focuses on classical hematology, particularly sickle cell disease and hemoglobinopathies, platelet disorders, thrombosis, and bone marrow failure syndromes. Dr. Morrone is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Banu Aygun is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Aygun is rated as an Elite provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Dr. Henny Billett has been Chief of the Division of Hematology since 2012 and Professor of Clinical Medicine and Pathology since 2002. Dr. Billett is rated as an Advanced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Mesenteric Venous Thrombosis, Antiphospholipid Syndrome, Sickle Cell Disease, Venous Thromboembolism (VTE), and Splenectomy.

Dr. Mapara is Professor of Medicine at Columbia University Medical Center and the Director of the Blood and Marrow Transplantation (BMT)/Cell Therapy Program at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Mapara graduated from the University of Heidelberg Medical School/Germany, and received his post-graduate training in Internal Medicine and Hematology/Oncology at the Universities of Heidelberg and the University Medical Center Charite of the Humboldt University of Berlin in Germany. In addition, he completed a research fellowship at the Transplantation Biology Research Center of the Massachusetts General Hospital at the Harvard Medical School in Boston. As Assistant Professor of Medicine, he headed the Hematologic Intensive Care Unit and served as deputy director of the Stem Cell Transplantation unit at the University Medical Center Charite in Berlin, Germany. Before coming to Columbia, Dr. Mapara was Associate Professor of Medicine (with tenure) at the University of Pittsburgh Cancer Institute and served as the Director of the Adult Hematopoietic Stem Cell Transplantation Program. Dr. Mapara specializes in the care of patients with sickle cell disease and certain blood cancers (Multiple Myeloma, Amyloidosis) undergoing bone marrow transplantation and gene therapy.  His research is focused on developing novel approaches to make bone marrow transplantation and cell therapy safer for patients. Dr. Mapara is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration.

Dr. Irina Murakhovskaya is an Assistant Professor of Medicine (Hematology). She completed a medical degree at Albert Einstein College of Medicine and residency and fellowship training at Montefiore Health System. Her clinical interests focus on monoclonal gammopathy, low-grade lymphoma, and hematologic issues in pregnancy. Dr. Murakhovskaya is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Autoimmune Hemolytic Anemia, Thrombocytopenia, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Dr. William Osler famously said, “The good physician treats the disease; the great physician treats the patient who has the disease.” I am a strong believer in individualizing treatment plans unique to each patient based on understanding the patient as a whole and the specifics of their disease. I am committed to each patient’s care and work hard to ensure that every single patient has the most positive clinical outcome. Dr. Goldfinger is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Mahvish Q. Rahim, MD, MS, MBA, is an attending physician at the Children’s Hospital at Montefiore Einstein and Assistant Professor, Pediatrics, Pediatric Hematology-Oncology and Stem Cell Transplant at our Albert Einstein College of Medicine. Dr. Rahim’s clinical focus centers on stem cell transplant and cellular therapy for patients with leukemia and sickle cell disease. She also has an interest in fertility preservation for pediatric hematology-oncology patients. Dr. Rahim is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Jennifer G. Davila, MD, is Co-Director, Hemophilia Treatment Center at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Dr. Davila focuses on the care of children with bleeding and clotting disorders. Dr. Davila is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Venous Thromboembolism (VTE), Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Bone Marrow Aspiration.

Dr. Lebelt obtained her medical degree in Medical Academy in Bialystok, Poland. In the US, she finished her Internal Medicine residency at Our Lady of Mercy Medical Center through New York Medical College. Her residency was followed up with a fellowship in Geriatric Medicine at the same institution. Dr. Skokowska is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Type 2 Diabetes (T2D), Hypertension, Glucocorticoid-Remediable Aldosteronism, Gastrostomy, and Endoscopy.

Nancy Green is a Pediatrics provider in New York, New York. Dr. Green is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Green is currently accepting new patients.

David Diuguid is an Oncologist in New York, New York. Dr. Diuguid is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Sickle Cell Disease, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), and Hemangioma Thrombocytopenia Syndrome. Dr. Diuguid is currently accepting new patients.

Dr. Mark Chaitowitz obtained his medical degree at the University of Witwatersrand in Johannesburg, South Africa. He relocated to the United States in 2001, where he completed his residency in internal medicine at Albert Einstein Medical Center, and fellowship in hematology and oncology at Thomas Jefferson University Hospital, both in Philadelphia. Dr. Chaitowitz is rated as an Experienced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), and Hemangioma Thrombocytopenia Syndrome.

Prakash Satwani, MD specializes in the use of bone marrow transplantation to treat children and adolescents with leukemia, lymphoma, or hemophagocytic lymphohistiocytosis. Bone marrow transplantation is a dynamic, intriguing field with multiple complex issues. Dr. Satwani has always enjoyed solving puzzles and is attracted to the intellectual challenge of caring for patients whose lives may be saved or extended with bone marrow transplantation. Dr. Satwani is also inspired and motivated by the long-lasting and rich relationships formed with patients and their families, and often keeps in touch with families long after their child's treatment has been completed. Dr. Satwani teaches medical students, residents, fellows, nurses, and nurse practitioners about bone marrow transplantation. It's important to educate people so they can learn the latest advances and provide the best care possible for patients. To continue to achieve those advances, Dr. Satwani conducts clinical research in reducing the life-threatening complications related to transplantation, such as infections and graft-versus-host disease. Dr. Satwani and colleagues also evaluate reduced-intensity bone marrow transplantation preparative regimens, which use lower doses of chemotherapy with the hope of decreasing short-term and long-term complications without compromising the effectiveness of treatment. Dr. Satwani is rated as an Advanced provider by MediFind in the treatment of Hemoglobinopathy. His top areas of expertise are Graft Versus Host Disease (GvHD), Anemia, Sickle Cell Disease, Leukemia, and Bone Marrow Transplant.

Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis).Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications. Dr. Lee is rated as an Advanced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Dr. Tolu is an Assistant Professor of Medicine in the Division of Hematology and Oncology, Center for Lymphoid Malignancies, at the Herbert Irving Comprehensive Cancer Center of Columbia University Irving Medical Center. Dr. Tolu earned her undergraduate degree in Neurobiology & Physiology at University of Maryland followed by her Medical Doctorate from University of Maryland, Baltimore. She completed her Internal Medicine residency at Montefiore Medical Center/Albert Einstein College Medicine where she had the honor of serving as Chief Resident. Dr. Tolu then went on to complete her fellowship in Hematology & Oncology at Columbia University Irving Medical Center, where she also served as Chief Fellow. Throughout her career, Dr. Tolu has earned several awards and scholarships for her research and academic achievements including the Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Research Scholarship, the Research Training Award for Fellows (RTAF), the Conquer Cancer Foundation Young Investigator Award (YIA), and the Cutaneous Lymphoma Foundation (CLF) YIA. She was also selected to participate in the prestigious American Association for Cancer Research (AACR)/Molecular Biology in Clinical Oncology Workshop, the American Society of Hematology (ASH)/Clinical Research Training Institute (CRTI), the Academy of Next Wave of Clinical Investigators in Non-Hodgkin’s Lymphoma, and the Food & Drug Administration (FDA)/American Society of Clinical Oncology (ASCO) Fellows Workshop. She continues to serve as a member of the Alpha Omega Alpha (AOA) Honor’s Society. Dr. Tolu’s pre-clinical research focuses on identifying synergistic targeted therapies using novel methods to accurately recapitulate lymphoma biology. As a clinical investigator, Dr. Tolu is highly involved in numerous clinical trials at Columbia spanning across Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Peripheral T-cell Lymphomas, and Cutaneous T-cell Lymphomas. Dr. Tolu is rated as an Advanced provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

Abena Appiah is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Appiah is rated as a Distinguished provider by MediFind in the treatment of Hemoglobinopathy. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.